These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31876269)

  • 1. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
    Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
    Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
    Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
    Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
    Gong X; Ning B
    Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
    Ma Z; Wang J; Ding L; Chen Y
    Medicine (Baltimore); 2020 Jul; 99(28):e21158. PubMed ID: 32664150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.
    Huang H; Zhang Q; Ye C; Lv JM; Liu X; Chen L; Wu H; Yin L; Cui XG; Xu DF; Liu WH
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2571-2579. PubMed ID: 28849390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analyses identify potential prognostic markers for uveal melanoma.
    Ni Y; Zhang Z; Chen G; Long W; Tong L; Zeng J
    Exp Eye Res; 2019 Oct; 187():107780. PubMed ID: 31469983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
    Chen Q; Hu J; Deng J; Fu B; Guo J
    Biomed Res Int; 2019; 2019():3917982. PubMed ID: 31828101
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
    Zhao Y; Tao Z; Li L; Zheng J; Chen X
    BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
    Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
    Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
    Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S
    Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer.
    Shen H; Guo YL; Li GH; Zhao W; Zhang L
    Comput Math Methods Med; 2021; 2021():9946015. PubMed ID: 34497666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer.
    Li C; Pang L; Jin F; Song Y; Zhou D; Song Y; Li Y; Jin S; Zhang L; Liang W; Shen X; Li J; She B; Wang C; Ma L
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.